Reduced tumour necrosis factor receptor superfamily 13C inversely correlated with tumour necrosis factor superfamily 13B in patients with immune thrombocytopenia

Authors:

Abstract
To investigate the expression of tumour necrosis factor superfamily 13B (TNFSF13B) receptors in immune thrombocytopenia (ITP) and their correlation with disease activity, we investigated the protein and mRNA levels of TNFSF13B, tumour necrosis factor receptor superfamily 13C (TNFRSF13C), TNFRSF13B and TNFRSF17 by flow cytometry, enzyme‐linked immunosorbent assay and real time quantitative polymerase chain reaction. All CD19+B lymphocytes expressed TNFRSF13C by flow cytometry, but the mean fluorescence intensity (MFI) was decreased in patients with active disease compared to patients in remission and healthy controls, while no significant difference of TNFRSF13C mRNA was found between ITP patients and controls. The mRNA and plasma TNFSF13B were elevated in active ITP patients, and TNFRSF13C MFI level was inversely correlated with plasma TNFSF13B in active patients. In vitro assays showed that TNFRSF13C MFI was decreased after long exposure to TNFSF13B. No significant difference for TNFRSF13B or TNFRSF17 was found between ITP patients and controls. In conclusion, TNFRSF13C expression is reduced on CD19+ cells in active ITP patients. This down‐regulation occurs through a post‐transcriptional mechanism and could be a consequence of chronic increase of TNFSF13B.
Funding Information
  • National Natural Science Foundation of China (81100335,81070396,81100334,81100336,81100348,81101869,81170475,81200344,81202307, 81270578, 81300383)
  • National Natural Science Foundation of China (81370623,81370616,81300384)
  • National Basic Research Program of China (973 Program, No. 2009CB521904, No. 2011CB503906)
  • National High Technology Research and Development Program of China (863 Program, No. 2012AA02A505))
  • National Natural Science Funds for Distinguished Young Scholar (81125002)
  • National Public Health Grand Research Foundation (201202017)
  • Outstanding Young Scientist Research Award Foundation of Shandong Province (No. 2008BS03025, No. BS2010YY024, No. BS2010YY039, No. BS2011SW013, No. BS2011YY021)
  • State Key Clinical Specialty of China for Blood Disorders, the Research Fund for the Doctoral Program of Higher Education of China (20100131120058)
  • State Program of National Natural Science Foundation of China for Innovative Research Group (81321061)

This publication has 59 references indexed in Scilit: